Cargando…
Central sympatholytics prolong survival in experimental sepsis
INTRODUCTION: One of the main causes of death in European and US intensive care units is sepsis. It involves a network of pro-inflammatory cytokines such as TNF-α, IL-1β and IL-6. Furthermore, there is an up regulation of transcription factors such as nuclear factor (NF) κB. It has previously been s...
Autores principales: | Hofer, Stefan, Steppan, Jochen, Wagner, Tanja, Funke, Benjamin, Lichtenstern, Christoph, Martin, Eike, Graf, Bernhard M, Bierhaus, Angelika, Weigand, Markus A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688128/ https://www.ncbi.nlm.nih.gov/pubmed/19196475 http://dx.doi.org/10.1186/cc7709 |
Ejemplares similares
-
Redox Responses in Patients with Sepsis: High Correlation of Thioredoxin-1 and Macrophage Migration Inhibitory Factor Plasma Levels
por: Brenner, Thorsten, et al.
Publicado: (2010) -
Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis
por: Bopp, Christian, et al.
Publicado: (2008) -
Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction
por: Hofer, Stefan, et al.
Publicado: (2009) -
The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation
por: Kayhan, Nalan, et al.
Publicado: (2008) -
Pharmacologic inhibition of cholinesterase improves survival in experimental sepsis
por: Hofer, S, et al.
Publicado: (2007)